Ipca Laboratories acquires 80% stake in Bayshore Pharmaceuticals

Through its wholly owned subsidairy Ipca Pharmaceuticals Inc., USA

Ipca Laboratories announced that its wholly owned subsidiary, Ipca Pharmaceuticals Inc., USA has acquired, on 2 October 2018, 80% share capital of Bayshore Pharmaceuticals LLC, a New Jersey limited liability company (Bayshore), 788 Morris Turnpike, Suite 200, Short Hills, New Jersey, USA for cash @ US $ 10.286 millions.

For its financial year ended 31 December, 2017, Bayshore had a total income of US $ 7.05 millions and EBIDTA of US $ 0.56 million.

Powered by Capital Market - Live News